June 2024 - HempWire

ThursdayJun 27, 2024 10:00 am

CRS Says ‘Miller Amendment’ Won’t Ban CBD, Other Cannabinoids from Hemp

An analysis conducted by the Congressional Research Service has determined that not all hemp cannabinoids will be prohibited under a recently proposed amendment for the upcoming Farm Bill. The legislative agency stated that the amendment, which would crack down on the distribution of unregulated hemp products, wouldn’t affect nonpsychoactive natural compounds from the hemp crop, including CBD. The amendment to the farm bill, dubbed the Miller Amendment, was introduced by Representative Mary Miller of Illinois. It was approved by the House Committee on Agriculture in May 2024. The amendment defines hemp in a different way, differentiating between industrial hemp, which…

WednesdayJun 26, 2024 9:00 am

Golden Triangle Ventures Inc. (GTVH), Largest Note Holder Reach Agreement That Will Enhance Shareholder Value

GTVH enters pivotal agreement with largest note holder, T&K Zarro LLC CEO notes that agreement demonstrates “our commitment to strengthening our capital structure and delivering tangible value to our shareholders” The agreement is a “testament” to the company’s strategic foresight and dedication to fostering a robust and scalable business model Golden Triangle Ventures (OTC: GTVH) continues momentum as the company announces strategic steps in its commitment to solidifying its capital structure, expanding its business operations and enhancing shareholder value. Most recently, the company revealed a pivotal agreement with T&K Zarro LLC, GTVH’s largest note holder (https://cnw.fm/3mhs9). “This agreement marks a…

TuesdayJun 25, 2024 10:00 am

Colorado AG Sues Firm That Sold Marijuana While Calling It Hemp

Attorney General Phil Weiser is suing a marijuana product retailer in Colorado for selling cannabis marketed as industrial hemp. The retailer, Gee Distributors, is based in Greely and operates as CBDDY. The business’ owner, Christopher Landon Eoff, is also being sued by the AG. Under the Colorado Consumer Protection Act, any misleading, misrepresenting and false advertisements are prohibited deceptive trade practices. A recent announcement made by the attorney general’s office revealed that the suit was filed in the Weld County District Court and marked the first action against the business. The lawsuit claims that some of the products sold by…

MondayJun 24, 2024 12:00 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Completes Second Round of Dosing for Human Pilot Study #2; Set to Complete Third Study Arm in Early July

Lexaria, a global innovator in drug delivery platforms, has announced the successful completion of its second round of dosing for its human pilot study #2 The final study arm is set for completion in early July, and if successful, it will help remedy the downsides of swallowed administration The study’s main objective is to evaluate Lexaria’s patented DehydraTECH(TM) technology for the oral delivery of the glucagon-like peptide-1 (“GLP-1”) drug, semaglutide, currently commercially available as Rybelsus(R) The commencement of the pilot study shows Lexaria’s commitment to its promise to focus on GLP-1 studies for 2024, along with its confidence in its…

MondayJun 24, 2024 9:45 am

Golden Triangle Ventures Inc. (GTVH) Completes Acquisition of Time-Tested, Proven Shipping and Logistics Operation

Through acquisition, management has agreed to use 10% of the profits from logistics business to buy back and retire GTVH stock “This transition marks a pivotal moment in our journey,” states exec Management is crafting a comprehensive business plan that substantially expands the company’s growth trajectory Golden Triangle Ventures (OTC: GTVH) continues to take strategic steps toward expanding and positioning the company for fundamental business income and financial independence. The latest in these steps is the completed acquisition of Cargo Management Group, a multifaceted logistics and trucking operation (https://cnw.fm/IjALN). According to the announcement, through this acquisition, management has agreed to use 10%…

ThursdayJun 20, 2024 10:00 am

Massachusetts Regulators Grapple with Wave of Hemp-Derived Intoxicants

Legislators in the state of Massachusetts are working toward interventions that will curb the use and/or proliferation of intoxicating hemp-based products. Hemp-derived intoxicants aren’t legal. Federally, hemp is defined as cannabis that contains no more than 0.3% THC when harvested. THC is one of the primary compounds of marijuana, the other being CBD. Unlike CBD, however, THC induces a high when ingested. However, when the 2018 Farm Bill eliminated hemp from the list of Controlled Substances and allowed the crop’s cultivation, a gray area that allowed this market to thrive was created. Popular hemp-based products include Delta-10 and Delta-8, and…

TuesdayJun 18, 2024 10:00 am

Language in Federal Spending Bill Could Accelerate Clampdown on Hemp Intoxicants

A recently released federal spending bill includes language that would put an end to the distribution of unregulated hemp products. Provisions in the new spending bill would distinguish between industrial hemp cultivated for food and fiber and plants cultivated to produce cannabinoid extracts. The definition of hemp, under the new bill, includes naturally occurring and derived cannabinoids. Substances manufactured or synthesized from the plant, such as delta-8 THC, THCP, HHC, THC-O-acetate and delta-10 THC, will no longer meet the legal hemp definition. The market is filled with these intoxicating products, thriving after the 2018 Farm Bill legalized hemp and left…

MondayJun 17, 2024 11:15 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires CRO; Set for First Tirzepatide Molecule Study

Lexaria, a global innovator in drug delivery platforms, recently announced the hiring of a Contract Research Organization (“CRO”) for its third human pilot study The study, a randomized, crossover investigation, will evaluate a dual-action glucagon-like peptide 1 (“GLP-1”) + glucose-dependent insulintropic peptide (“GIP”) It will measure absorption, tolerability, pharmacokinetics, and blood sugar levels Lexaria is counting on its patented DehydraTECH technology for significant growth in the 2024 calendar year, and the study reflects this commitment Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just announced the hiring of a Contract Research Organization (“CRO”) for its third human…

FridayJun 14, 2024 9:45 am

Astrotech Corp. (NASDAQ: ASTC) Expands Role of Mass Spectrometry in Industrial Processes

In the chemical manufacturing industry, innovative uses of mass spectrometry are a game-changer by ensuring quality control, increased yields, and increased profits Astrotech subsidiary, Pro-Control Inc., has positioned its product line between the need for the chemical manufacturers to offset lower prices with efficiency gains that could offset potential losses The Pro-Control Maximum Value Processing(TM) can perform in-situ process tests every 5 minutes greatly increasing efficiency across a wide range of chemical manufacturing processes Mass spectrometry (“MS”) is becoming a transformative analytical technique that has revolutionized how materials are tested and processed in various industries, such as petrochemical. The supreme…

FridayJun 14, 2024 9:00 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Advances Therapies Targeting Neurodegenerative Diseases

INM is advancing INM-089 targeting age-related macular degeneration and INM-901 targeting Alzheimer’s disease The company recently posted positive results for INM-089 demonstrating significant functional and pathological improvements in an AMD disease model Recent preclinical data for INM-901 displayed positive pharmacological effects for treating Alzheimer's disease INM posted a business update for Q3-2024 reporting a closing cash position of US$7.9 million and revenue growth for subsidiary BayMedica, a supplier of rare cannabinoids as ingredients InMed Pharmaceuticals (NASDAQ: INM), a is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. InMed’s…

News and publishing service for hemp related companies

Contact us: 303.498.7722

Month: June 2024